How antiretroviral therapy has revolutionized pregnancy outcomes for HIV-positive women, reducing transmission rates to less than 1%.
Breakthrough research on using sofosbuvir/velpatasvir (SOF/VEL) to treat Hepatitis C in pregnant women and prevent mother-to-child transmission.